Enables Agenus to accelerate development of its lead BOT/BAL programme and strategically expand into high-unmet need indications and earlier lines of treatment. Agenus' lead programme comprising ...
NEW YORK & DENVER--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Pipeline, a Denver-based startup that uses artificial intelligence (AI) ...
Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...
The MarketWatch News Department was not involved in the creation of this content. Financing led by Pfizer Ventures will support advancement of lead program CBI-1214 into a Phase 1 trial, targeted for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In two joint ventures with MPLX ...
Financing led by Pfizer Ventures will support advancement of lead program CBI-1214 into a Phase 1 trial, targeted for enrollment in early 2026, and expand next wave of programs from the ATLAS and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback